Search

Chandrasekar Venkataramani

from San Carlos, CA
Age ~50
Get Report
Also known as:
Chandrasekar Venkatarama, Chandrasekar Venkateramani, Chandraseka Venkada
Phone and address:
3394 Melendy Dr, San Carlos, CA 94070
Related to:
C Venkataramani
Connected to:
Aditya Venkatachalam, 36Ananthkumar P Venkatachalapathi, 48Arunkumar Venkataramani, 46Bala V Venkatasubramanian, 57Bharath R Venkat, 40Bharaty Y Venkatanarayanan, 61Chandrasekar Venkataraman, 53Chaya R Venkat, 76Deepthi Venkatachalam, 37Ganesan Venkataraman, 40

Chandrasekar Venkataramani Phones & Addresses

  • 3394 Melendy Dr, San Carlos, CA 94070
  • 1 Chart Ln, Redwood City, CA 94065
  • Tonawanda, NY
  • San Mateo, CA
  • Lockport, NY
  • Oxford, OH

Work

Company: Gilead sciences Jan 2019 Position: Principal scientist i

Education

Degree: Doctorates, Doctor of Philosophy School / High School: State University of New York College at Buffalo 1998 to 2002

Languages

English

Industries

Pharmaceuticals

Resumes

Resumes

Chandrasekar Venkataramani Photo 1

Principal Scientist I

View page
Location:
3394 Melendy Dr, San Carlos, CA 94070
Industry:
Pharmaceuticals
Work:
Gilead Sciences
Principal Scientist I
Gilead Sciences 2018 - 2019
Senior Research Scientist Ii
Gilead Sciences 2012 - 2018
Senior Research Scientist I
Gilead Sciences Dec 2007 - Jan 2012
Research Scientist Ii
Portola Pharmaceuticals Apr 2005 - 2007
Scientist Ii
Education:
State University of New York College at Buffalo 1998 - 2002
Doctorates, Doctor of Philosophy Indian Institute of Technology, Delhi 1995 - 1997
Master of Science, Masters, Organic Chemistry
Languages:
English

Business Records

Name / Title
Company / Classification
Phones & Addresses
Chandrasekar Venkataramani
TACK SHARP STUDIOS, LLC

Publications

Us Patents

Inhibitors Of Syk And Jak Protein Kinases

View page
US Patent:
8063058, Nov 22, 2011
Filed:
Apr 16, 2009
Appl. No.:
12/386525
Inventors:
Zhaozhong J. Jia - San Mateo CA, US
Chandrasekar Venkataramani - Redwood City CA, US
Wolin Huang - Foster City CA, US
Mukund Mehrotra - South San Francisco CA, US
Yonghong Song - Foster City CA, US
Qing Xu - Foster City CA, US
Shawn M. Bauer - Pacifica CA, US
Jack W. Rose - San Mateo CA, US
Brian Kane - Pleasant Hill CA, US
Anjali Pandey - Fremont CA, US
Assignee:
Portola Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A01N 43/54
A61K 31/505
C07D 401/00
C07D 403/00
C07D 405/00
C07D 409/00
C07D 411/00
C07D 413/00
C07D 417/00
C07D 419/00
US Classification:
514275, 544324
Abstract:
The present invention is directed to compounds of formula I-V and tautomers thereof or pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk kinase activity, methods of inhibition the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk kinase activity, such as undesired thrombosis and Non Hodgkin's Lymphoma.

Cycloalkylidene And Heterocycloalkylidene Inhibitor Compounds

View page
US Patent:
8088771, Jan 3, 2012
Filed:
Jul 28, 2009
Appl. No.:
12/510809
Inventors:
Michael Graupe - Pacifica CA, US
Chandrasekar Venkataramani - Redwood City CA, US
Juan A. Guerrero - Concord CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
A61K 31/5377
A61K 31/4178
A61K 31/4965
A61K 31/497
C07D 405/14
C07D 417/14
US Classification:
5142368, 5142531, 51425505, 514397, 544133, 544364, 544405, 5483111
Abstract:
The present invention provides a compound of general Formula (I) having histone deacetylase (HDAC) inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound.

Fused Heterocyclyc Inhibitor Compounds

View page
US Patent:
8124764, Feb 28, 2012
Filed:
Jul 14, 2009
Appl. No.:
12/502967
Inventors:
Michael Graupe - Pacifica CA, US
Chandrasekar Venkataramani - Redwood City CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
C07D 401/00
US Classification:
544331, 544179, 544180, 544185, 544215, 5462684, 514183, 514242, 514245, 51425205, 514336
Abstract:
The present invention provides a compound of general Formula (I) having histone deacetylase (HDAC) and/or Cyclin-dependent kinase (CDK) inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound.

Imidazolyl Pyrimidine Inhibitor Compounds

View page
US Patent:
8134000, Mar 13, 2012
Filed:
Jul 14, 2009
Appl. No.:
12/502870
Inventors:
Chandrasekar Venkataramani - Redwood City CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
C07D 401/00
US Classification:
544331, 544179, 544180, 544185, 544215, 5462684, 514183, 514242, 514245, 51425205, 514336
Abstract:
A compound of general Formula (I) having histone deacetylase (HDAC) and/or Cyclin-dependent kinase (CDK) inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound.

Inhibitors Of Protein Kinases

View page
US Patent:
8138339, Mar 20, 2012
Filed:
Apr 16, 2009
Appl. No.:
12/386509
Inventors:
Shawn M. Bauer - Pacifica CA, US
Zhaozhong J. Jia - San Mateo CA, US
Yonghong Song - Foster City CA, US
Qing Xu - Foster City CA, US
Mukund Mehrotra - South San Francisco CA, US
Jack W. Rose - San Mateo CA, US
Wolin Huang - Foster City CA, US
Chandrasekar Venkataramani - Redwood City CA, US
Anjali Pandey - Fremont CA, US
Assignee:
Portola Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C07D 239/28
C07D 403/02
C07D 413/02
C07D 279/12
A61K 31/506
A61K 31/501
A61K 31/5377
A61K 31/551
A61K 31/541
US Classification:
544297, 544295, 544122, 544 582, 5442278, 514275, 514249, 5142358, 514218, 5142278, 540601
Abstract:
The present invention is directed to 2-cycloalkylamino-4-arylamino-benzamide compounds of formula I pharmaceutically acceptable salts thereof which are inhibitors of syk and/or JAK kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk and/or JAK kinase activity, and methods to prevent or treat a number of conditions mediated at least in part by syk and/or JAK kinase activity, such as cardiovascular disease, inflammatory disease, autoimmune disease and cell proliferative disorder.

Cycloalkylidene And Heterocycloalkylidene Inhibitor Compounds

View page
US Patent:
8198299, Jun 12, 2012
Filed:
Oct 28, 2011
Appl. No.:
13/284559
Inventors:
Michael Graupe - Pacifica CA, US
Chandrasekar Venkataramani - Redwood City CA, US
Juan A. Guerrero - Concord CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
A61K 31/437
A61K 31/4433
A61K 31/4196
C07D 513/04
C07D 405/04
C07D 249/08
US Classification:
514301, 514336, 514383, 546114, 5462821, 5482622
Abstract:
The present invention provides a compound of general Formula (I) having histone deacetylase (HDAC) inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound.

Alkanoylamino Benzamide Aniline Hdac Inhibitor Compounds

View page
US Patent:
8258316, Sep 4, 2012
Filed:
Jun 7, 2010
Appl. No.:
12/795554
Inventors:
Michael Graupe - Pacifica CA, US
Chandrasekar Venkataramani - Redwood City CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
C07D 207/08
A61K 31/4025
US Classification:
548568, 514428
Abstract:
The present invention provides a compound of general Formula (I) having histone deacetylase (HDAC) inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound.

Cycloalkylcarbamate Benzamide Aniline Hdac Inhibitor Compounds

View page
US Patent:
8283357, Oct 9, 2012
Filed:
Jun 7, 2010
Appl. No.:
12/795575
Inventors:
Chandrasekar Venkataramani - Redwood City CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
A61K 31/4468
C07D 211/56
US Classification:
514278, 546 16
Abstract:
The present invention provides a compound of general Formula (I) having histone deacetylase (HDAC) inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound.
Control profile
Chandrasekar Venkataramani from San Carlos, CA, age ~50 Get Report